Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Farmers Insurance
Cantor Fitzgerald
McKinsey
Novartis
AstraZeneca
Chubb
Mallinckrodt
Express Scripts
Boehringer Ingelheim

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016848

« Back to Dashboard
NDA 016848 describes ANADROL-50, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. Additional details are available on the ANADROL-50 profile page.

The generic ingredient in ANADROL-50 is oxymetholone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the oxymetholone profile page.

Summary for NDA: 016848

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 016848

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANADROL-50
oxymetholone
TABLET;ORAL 016848 NDA Alaven Pharmaceutical 68220-055 68220-055-10 1 BOTTLE in 1 CARTON (68220-055-10) > 100 TABLET in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
AstraZeneca
US Department of Justice
Deloitte
Daiichi Sankyo
Mallinckrodt
Fish and Richardson
Express Scripts
Medtronic
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot